IVVD Insider Trading

Insider Ownership Percentage: 17.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $20,188,546.27

Invivyd Insider Trading History Chart

This chart shows the insider buying and selling history at Invivyd by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invivyd Share Price & Price History

Current Price: $0.44
Price Change: Price Increase of +0.0142 (3.30%)
As of 12/20/2024 06:31 PM ET

This chart shows the closing price history over time for IVVD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Invivyd Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2024Terrance McguireDirectorSell74,764$0.47$35,139.083,840,146View SEC Filing Icon  
12/16/2024Terrance McguireDirectorSell65,359$0.47$30,718.734,012,320View SEC Filing Icon  
12/11/2024Terrance McguireDirectorSell160,400$0.59$94,636.004,202,679View SEC Filing Icon  
12/9/2024Terrance McguireDirectorSell150,000$0.61$91,500.004,538,079View SEC Filing Icon  
5/29/2024Terrance McguireDirectorSell112,381$1.66$186,552.464,688,079View SEC Filing Icon  
1/19/2024Adimab, LlcMajor ShareholderSell5,000,000$3.95$19,750,000.0021,687,906View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Invivyd (NASDAQ:IVVD)

70.36% of Invivyd stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IVVD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Invivyd Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC117,973$0.12M0.0%+179.6%0.099%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,622,221$1.66M0.0%-0.8%1.358%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC117,973$0.12M0.0%+179.6%0.099%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC30,074$31K0.0%-32.7%0.025%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,018,640$1.04M0.0%+3.7%0.853%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.547,290$0.56M0.0%-20.4%0.458%Search for SEC Filing on Google Icon
11/13/2024FMR LLC7,320,982$7.47M0.0%-12.5%6.129%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.210,749$0.22M0.0%-57.9%0.176%Search for SEC Filing on Google Icon
11/1/2024Proficio Capital Partners LLC26,706$27K0.0%N/A0.022%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC134,452$0.15M0.0%+66.1%0.113%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.35,022$39K0.0%-53.4%0.029%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC104,732$0.12M0.0%N/A0.088%Search for SEC Filing on Google Icon
8/15/2024Dimension Capital Management LLC189,871$0.21M0.0%+243.3%0.159%Search for SEC Filing on Google Icon
8/15/2024Duquesne Family Office LLC571,425$0.63M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.35,022$39K0.0%-53.4%0.029%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC134,452$0.15M0.0%+66.1%0.113%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP786,899$0.87M0.0%+4.2%0.660%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd37,938$42K0.0%+68.1%0.032%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC36,570$40K0.0%-67.3%0.031%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC382,818$0.42M0.0%N/A0.321%Search for SEC Filing on Google Icon
8/8/2024Cornercap Investment Counsel Inc.77,753$86K0.0%N/A0.065%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC678,706$0.75M0.0%+232.0%0.569%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers84,017$92K0.0%+4,434.1%0.070%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp239,373$0.26M0.0%N/A0.201%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC37,893$42K0.0%+198.6%0.032%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC28,337$0.13M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.435,338$1.93M0.0%+21.7%0.365%Search for SEC Filing on Google Icon
5/16/2024Bain Capital Life Sciences Investors LLC1,799,595$7.99M0.6%-7.1%1.508%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC204,405$0.91M0.0%N/A0.171%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,611,202$11.59M0.0%+3.9%2.190%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC12,692$56K0.0%N/A0.011%Search for SEC Filing on Google Icon
5/7/2024Marquette Asset Management LLC14,083$63K0.0%-67.3%0.012%Search for SEC Filing on Google Icon
5/2/2024Chase Investment Counsel Corp61,097$0.27M0.1%N/A0.051%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC17,575$69K0.0%-13.2%0.016%Search for SEC Filing on Google Icon
2/6/2024a16z Perennial Management L.P.79,869$0.32M0.0%N/A0.073%Search for SEC Filing on Google Icon
1/11/2024Naples Global Advisors LLC10,000$39K0.0%-50.0%0.009%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.509,165$0.87M0.0%-78.1%0.462%Search for SEC Filing on Google Icon
11/13/2023FMR LLC8,060,939$13.70M0.0%-18.9%7.344%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.509,165$0.87M0.0%-78.1%0.464%Search for SEC Filing on Google Icon
11/8/2023Vanguard Personalized Indexing Management LLC20,243$34K0.0%N/A0.018%Search for SEC Filing on Google Icon
10/27/2023Marquette Asset Management LLC43,028$73K0.0%N/A0.039%Search for SEC Filing on Google Icon
10/27/2023Acuitas Investments LLC208,579$0.36M0.2%N/A0.190%Search for SEC Filing on Google Icon
10/16/2023Naples Global Advisors LLC20,000$34K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/14/2023683 Capital Management LLC4,000,000$4.20M0.3%+17.6%3.644%Search for SEC Filing on Google Icon
8/14/2023Shay Capital LLC87,395$92K0.0%+91.9%0.080%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.2,327,146$2.44M0.0%+187,270.9%2.126%Search for SEC Filing on Google Icon
7/24/2023BML Capital Management LLC134,696$0.14M0.1%N/A0.123%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC25,308$30K0.0%N/A0.023%Search for SEC Filing on Google Icon
5/16/2023Slate Path Capital LP3,735,000$4.48M0.2%N/A3.417%Search for SEC Filing on Google Icon
5/16/2023Bain Capital Life Sciences Investors LLC1,937,207$2.33M0.3%N/A1.772%Search for SEC Filing on Google Icon
5/15/2023Maverick Capital Ltd.1,887,527$2.27M0.1%N/A1.727%Search for SEC Filing on Google Icon
5/11/2023Alphabet Inc.5,680,785$6.82M0.4%N/A5.196%Search for SEC Filing on Google Icon
5/3/2023Triatomic Management LP25,800$31K0.0%N/A0.024%Search for SEC Filing on Google Icon
4/27/2023Strs Ohio24,300$29K0.0%N/A0.022%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Invivyd logo
Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. Its pipeline includes PEMGRADA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate which is in preclinical studies for the prevention or treatment for COVID-19; and adintrvimab, that is in phase 3 clinical trials for the prevention or treatment of COVID-19. The company also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Read More on Invivyd

Today's Range

Now: $0.44
Low: $0.40
High: $0.45

50 Day Range

MA: $0.78
Low: $0.43
High: $1.05

52 Week Range

Now: $0.44
Low: $0.40
High: $5.20

Volume

2,334,448 shs

Average Volume

664,642 shs

Market Capitalization

$53.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Who are the company insiders with the largest holdings of Invivyd?

Invivyd's top insider investors include:
  1. Adimab, Llc (Major Shareholder)
  2. Terrance Mcguire (Director)
Learn More about top insider investors at Invivyd.

Who are the major institutional investors of Invivyd?

Invivyd's top institutional shareholders include:
  1. FMR LLC — 6.13%
  2. Geode Capital Management LLC — 1.36%
  3. State Street Corp — 0.85%
  4. Jacobs Levy Equity Management Inc. — 0.46%
  5. Charles Schwab Investment Management Inc. — 0.18%
  6. Barclays PLC — 0.10%
Learn More about top institutional investors of Invivyd stock.

Which major investors are selling Invivyd stock?

Within the last quarter, IVVD stock was sold by these institutional investors:
  1. FMR LLC
  2. Charles Schwab Investment Management Inc.
  3. Jacobs Levy Equity Management Inc.
  4. Jane Street Group LLC
  5. Geode Capital Management LLC
During the previous year, company insiders that have sold Invivyd company stock include:
  1. Adimab, Llc (Major Shareholder)
  2. Terrance Mcguire (Director)
Learn More investors selling Invivyd stock.

Which major investors are buying Invivyd stock?

Within the previous quarter, IVVD stock was purchased by institutional investors including:
  1. Barclays PLC
  2. Barclays PLC
  3. State Street Corp
  4. Proficio Capital Partners LLC